Business Unit. Performance Materials. Innovative materials. Business Line Pharmaceutical Industry India. Think Asia. Think DKSH.
|
|
- Tamsyn Day
- 6 years ago
- Views:
Transcription
1 Business Unit Performance Materials Innovative materials for the pharmaceutical industry Business Line Pharmaceutical Industry India Think Asia. Think DKSH.
2 Ashland Inc., USA Polyplasdone XL (Type A) Crospovidone Conventional particle size grade Used as a disintegrant for IR tablets Polyplasdone XL-10 (Type B) Fine particle size grade Used as a disintegrant for ODT and provides smooth mouth feel Polyplasdone INF-10 (Type B) Very fine particle size grade Used as a suspending agent in oral suspension and also used as a disintegrant for pellets and MUPS Polyplasdone Ultra (Type A) Low peroxide content grade with conventional particle size Used as a disintegrant for IR tablets containing oxidation sensitive API Polyplasdone Ultra-10 (Type B) Low peroxide content grade with fine particle size Used as a disintegrant for ODT containing oxidation sensitive API Plasdone K-12 Plasdone K-17 Povidone/PVP Grade differentiation based on viscosity and K value Used as binder and vehicle for soft gelatin capsules and for drug solubilization Plasdone K-25 Plasdone K-29/32 Plasdone K-90 Plasdone K-90D Used as a binder for wet/dry granulation in tablets, capsules, pellets and powders Plasdone C-12 Plasdone C-17 Plasdone C-30 Pyrogen free grade Used as solublizer and suspension stabilizer for parenterals and ophthalmic formulations Plasdone S-630 Copovidone Plasdone S-630 is a binder and matrix polymer for solid dispersion formulations It is used to enhance solubility of poorly soluble drugs through melt extrusion or spray dried solid dispersion Klucel HF, HXF Pharm Klucel MF, MXF Pharm Klucel GF, GXF Pharm Klucel JF, JXF Pharm Hydroxypropyl cellulose (HPC) Grade differentiation based on Viscosity X' stands for fine particle size Used as a release retardant in CR Tablets and thickener for semisolids Used as a release retardant in CR Tablets and binder for solid oral formulations Klucel LF, LXF Pharm Klucel EF, EXF Pharm Klucel ELF Pharm Conventional grades used as binder for wet granulation and fine particle grade is used for dry granulation and direct compression Used in film coating system Low molecular weight Klucel used in melt extrusion 2
3 Ashland Inc., USA (Cont d) Benecel E4M Pharm* Benecel E10M Pharm* Hydroxypropyl methylcellulose/ Hypromellose (2910 substitution/ E Type) These grades can be used as hydrophilic release retardant for CR tablets Can also be used as a thickening agent to help prevent or minimize suspension settling without altering taste or mouth feel in liquid suspensions Benecel K100 LV PH PRM** Benecel K250 PH PRM** Benecel K750 PH PRM** Benecel K1500 PH PRM** Benecel K4M Pharm* Benecel K4M PH DC Benecel K15M Pharm* Benecel K15M PH DC Benecel K35M Pharm* Benecel K100M Pharm* Benecel K100M PH DC Benecel K200M Pharm* Hydroxypropyl methylcellulose/ Hypromellose (2208 substitution/ K Type) Differentiation based on viscosity 'DC' stands for direct compressible grade These grades can be used in single or in combination intragranularly or extragranularly as hydrophilic release retardant for CR tablets DC grades are used as direct compressible release retardant * CR grades available, ** Only CR grades available Benecel A15 LV PH PRM Methylcellulose Differentiation based on viscosity Benecel Methylcellulose used as granulating Benecel A15C Pharm agent and thickener. Low viscosity Benecel A15 LV is commonly Benecel A4M Pharm used in drug layering Benecel ME 233 P Pharm Aquarius Preferred HSC Aquarius Preferred HSP Aquarius Prime Aquarius Prime LS Aquarius Preferred MG Methylhydroxyethyl cellulose Ready-mix coating system It can be used as binder in solid orals and as rheology modifier in liquid orals and topicals High-solids coatings based on cellulosic polymers High-solids coatings based on copovidone with cellulosic polymers for significant improvements in adhesion and sprayable solids Coatings based on traditional cellulosic polymers Coatings based on cellulosic polymer and lactose This coating system reduces the moisture uptake 3
4 Ashland Inc., USA (Cont d) Aquarius Preferred TG Aquarius Preferred OG Aquarius Control ENA Aquarius Control SRX Ready-mix coating system This coating system masks the unpleasant taste of tablet This coating system masks the unpleasant odour of tablet Delayed-release (enteric) coatings based on methacrylic acid-ethyl acrylate copolymer Sustained release coatings based on ethylcellulose Blanose 7H4XF PH Blanose 7HF PH Blanose 7H3SF PH Blanose 7HOF PH Blanose 7M31F PH Blanose 7M8SF PH Blanose 7MF PH Blanose 7M1F PH Blnaose 7LF PH Blanose 9H4XF PH Blanose 9M31F PH Blanose 12M31P Blanose 12M8P Sodium CMC/ Carmellose sodium Differentiation based on viscosity and degree of substitution Used as a thickener/viscosity modifier in liquid orals/semi-solids Also used as a binder and release retardant for CR tablets Aqualon 7HF PH Aqualon 7H3SF PH Aqualon 7MF PH Aqualon 7M8SF PH Aqualon 7LF Aqualon 7L2P Aqualon 9M31F PH Aqualon 9M8F PH Aqualon 12M31P Sodium CMC/ Carmellose sodium Differentiation based on viscosity and degree of substitution Used as a thickener/viscosity modifier in liquid orals/semi-solids Also used as a binder and release retardant for CR tablets Aqualon EC T10 Pharm Ethyl cellulose Differentiation based on viscosity Used as a binder in direct compression due to its good flow and compactability Aqualon EC N7 Pharm Aqualon EC N10 Pharm Aqualon EC N14 Pharm Aqualon EC N22 Pharm Aqualon EC N50 Pharm Aqualon EC N100 Pharm Used for coating powder, granules and pellets to control drug release. Also used in seal coating 4
5 Ashland Inc., USA (Cont d) Natrosol 250 HHX/HHW Pharm Natrosol 250 HX Pharm, H Pharm Natrosol 250 M Pharm Natrosol 250 G Pharm Natrosol 250 L Pharm Hydroxyethyl cellulose Differentiation based on viscosity 'X' stands for fine particle size Used as a viscosity modifier in liquid orals and semi-solids Also used as release retardant in CR tablets Aquasolve L Hypromellose Dissolves at ph more than 5.8 Aquasolve M acetate succinate/hpmcas Dissolves at ph more than 6.0 Aquasolve H Dissolves at ph more than 6.8 Used as an enteric coating agent and as a solublizer for poorly soluble API in spray dried solid dispersions and hot melt extrusion Cavamax W6 Pharma a-cyclodextrin Oral grade Used to enhance solubility of Cavamax W7 Pharma b-cyclodextrin poorly soluble drugs in solid dispersions Cavamax W8 Pharma Used to mask unpleasant odour/ g-cyclodextrin taste of API and to stabilize the Cavasol W7 HP Pharma Hydroxypropyl b-cyclodextrin same Cavasol W8 HP Pharma Hydroxypropyl g-cyclodextrin Cavitron W7 HP5 Pharma Cavitron W7 HP7 Pharma Hydroxypropyl b-cyclodextrin Parenteral grade Used to increase solubility of drug in Parenterals Pharmasolve N-methyl-2- pyrrolidone Used as solubilizer and penetration enhancer in parenterals and topicals Crest Cellulose Pvt. Ltd., India Cellucrest 101 Microcrystalline cellulose Conventional particle size grade Conventional grade for wet and dry granulation Cellucrest 102 Coarser particle size Filler for direct compression. Improves flow property and compressibility Cellucrest 112 Low moisture, coarser particle size Filler for direct compression of moisture sensitive product Cellucrest 113 Low moisture, fine particle size Improves stability of moisture sensitive product 5
6 Crest Cellulose Pvt. Ltd., India (Cont d) Cellucrest 200 Microcrystalline cellulose Largest particle size Improves flow of blend for direct compression and dry granulation. Also reduces weight variation and variation in content uniformity Cellucrest 301 High bulk density grade To achieve efficient mixing of blend to manufacture small tablets and reduces weight variation and variation in content uniformity Cellucrest 302 High bulk density grade with coarser particle size To achieve efficient mixing of blend to manufacture small tablets and reduces weight variation and variation in content uniformity Rapigel Sodium starch glycolate Used as a disintegrant for IR tablets, capsules and ODT Lubricrest Magnesium stearate Lubricant Crestcross Crestadd Gelmac Croscarmellose sodium Dicalcium phosphate anhydrous/ Dicalcium phosphate dihydrate Pregelatinized maize starch Used as a disintegrant for IR tablets, capsules and ODT Used as a filler in wet granulation Used as a binder Symega Flavours, India Flavor (Liquid form) Spray Dried Flavor (Powder form) Bitter Taste Masker Natural flavor Nature identical flavor Synthetic flavor Flavoring agent for liquid orals Flavoring agent for ODT, effervescent powder, granules and tablets Unique combinations for bitter taste masking Functional Flavor Delivery of nutraceutical actives for gut health 6
7 Stepan, USA Stepanol WA 100 Sodium lauryl sulphate Oral grade, needle like crystals Used as a wetting agent in tablets, liquid orals and semi-solids Mondo Minerals B.V., Netherlands Microtalc Pharma 50 Talc/Hydrated Standard Particle Size grade Used as an antiadherant for tablets Microtalc Pharma 30 Microtalc Pharma 8 Magnesium Silicate Fine particle size grade Very fine particle size grade Used for drug layering in pellets and also used as anti tacking agent in film coating system JMC Corporation, Korea Sodium saccharin, 15% moisture Sodium saccharin, 6% moisture Sodium saccharin Used as a sweetner in powder, granules, ODT and liquid orals Precheza A.S., Czech Republic Pretiox AV 01 PhG Titanium dioxide Used as an opacifier in capsule shell and color coating system 7
8 Freund Corporation, Japan Dilactose R Dilactose F Dilactose S Lactose monohydrate (Granulated) Grade differentiation based on particle size Used in direct compression formulations to provide good flow and superior compressibility. Tablets manufactured with Dilactose provides quick disintegration Daicel Corporation, Japan GNF-D211 GNF-D215 Co-Processed excipient (D-Mannitol, Microcrystalline cellulose, Crospovidone, Carboxymethyl cellulose) Co-processed excipient for ODT Kimica Corporation, Japan Kimica Acid SN Kimica Acid SEB Alginic acid Complying NF (National Formulary) Complying to EP and BP Used as a disintegrant in anti-reflux and effervescent tablets Kimica Algin ULV-L3 Kimica Algin ULV-L5 Kimica Algin ULV-1 Kimica Algin ULV-3 Kimica Algin ULV-5 Sodium alginate Ultra low viscosity sodium alginate Used as a gelling agent in anti-reflux suspensions and effervescent tablets Kimica Algin IL-2 Kimica Algin IL-6 Kimica Algin I-1 Kimica Algin I-3 Kimica Algin I-5 Kimica Algin I-8 Kimica Algin I-S Sodium alginate Standard type sodium alginate Used in controlled release formulations 8
9 Kimica Corporation, Japan (Cont d) Kimica Algin LZ-2 Sodium alginate Ultra high viscosity sodium alginate Used in controlled release formulations Kimica Algin ULV-1G Kimica Algin ULV-5G Kimica Algin IL-6G Kimica Algin I-1G Kimica Algin I-3G Sodium alginate High stiffness gelation type Sodium Alginate Kimiloid LVC Kimiloid HVC Propylene glycol alginate Standard Type Propylene Glycol Alginate Used as a suspending agent, emulsion stabilizer, plasticiser and binder Kimiloid AB Kimiloid LLV Kimiloid NLS-K Kimiloid LV Kimiloid MV Kimiloid HV High esterification type Propylene Glycol Alginate Kimica Algin K Potassium alginate Dental impression material Kimica Algin Ca Calcium alginate Gelling agent Kimica Algin NH Ammonium alginate Dental impression material Kimica Algin Mag Magnesium alginate Anti reflux suspensions for infants NOF Corporation, Japan NOF CORPORATION Polysorbate 20 Polysorbate 80 GS Polysorbate 80 HX2 Polyoxyethylene sorbitan monolaurate/polysorbate 20 Polyyoxyethylene Sorbitan monooleate/polysorbate 80 Used as a solublizer in parenterals Used as a solublizer in parenterals High purity solubilizer for parenterals Sunbright DKH-02HB PEG 200 Parenteral grade Used as a solublizer in parenterals Sunbright DKH-03HB PEG 300 Sunbright DKH-04HB PEG 400 Activated PEGs Methoxy-polyethylene glycols (mpegs) Used for targeted drug delivery system 9
10 NOF Corporation, Japan (Cont d) NOF CORPORATION Phospholipids from Natural Sources Synthetic Phospholipids HSPC (Hydrogenated soyabean phosphatidylcholine EPC (Egg phosphatidylcholine) HEPC (Hydrogenated egg phosphatidylcholine) Egg sphingomyelin/ Milk sphingomyelin Different derivatives of phosphocholine Different derivatives of phosphatidylglycerol Different derivatives of phosphatidic acid, sodium salts Different derivatives of phosphotidylethanolamine Different derivatives of phosphatidylserine Used in liposomes Used in liposomes Fresenius Kabi, Germany Purified Egg Phospholipids PL 90 Purified egg phospholipids Parenteral grade Used as an emulsifier in injectables Wacker Chemie AG, Germany Cavamax W8 - CoQ10 complex Highly bioavailable CoQ10 Cardiovascular health 10
11 Wacker Chemie AG, Germany (Cont d) Cavacurcumin Highly bioavailable curcumin Anticancer/antiinflammatory HTEssence Hydroxytyrosol Antioxidant for Cardiovascular health/ skin lightening Horphag Research, Switzerland Pycnogenol French maritime pine bark extract Cardiovascular health Improves endothelial function Normalises high blood pressure Diabetes Joint health Oral skin care/topical skin care Sports nutrition Erectile dysfunction Robuvit French oak extract Chronic fatigue syndrome Clariant, Switzerland Polyglykol 300 Polyglykol 400 Polyglykol 600 Polyethylene glycols/ Macrogols Brand name followed by numbers indicate the average molecular weight The high solvent power leads to a broad use of low molecular weight PEGs in liquid preparations such as drops, parenterals or fillings for gelatin capsules Polyglykol 1000 Polyethylene glycols/ Macrogols Used to make ointment base Lanogen 1500 Polyethylene glycols/ Macrogols Ointment base (JP) containing Polyglykol 300 and 1500 in a ratio of 1:1. Used as an ointment base 11
12 Clariant, Switzerland (Cont d) Polyglykol 1500 S Polyglykol 2000 S Polyglykol 3000 S/P Polyglykol 3350 S/P/PS Polyglykol 4000 S/P/PF/ PS Polyglykol 6000 S/P/PF Polyglykol 8000 S/P/PF Polyglykol S/P Polyglykol S/P Polyglykol S/P Polyglykol S Polyethylene glycols/ Macrogols Brand name followed by numbers indicate the average molecular weight S' stands for flakes 'P' stands for powder 'PF' stands for fine powder 'PS' stands for spray dried powder Solid PEGs are preferred bases for suppository masses. PEGs can be used as carriers, solubilizers and absorption improvers for active substances, usually processed in the form of a melt (melt granulation) They also act as lubricants and binders during tablet processing PEGs also has a plasticizing effect which facilitates the shaping of the tablet mass in the compression process and may counteract capping Solid PEGs are also frequently used in tablet coatings as a plasticizer. The flexibility of sugar-coated tablets is increased by PEGs The USP/NF describes a blend in the monograph PEG 3350 and Electrolytes for Oral Solution as a laxative preparations which contains a detailed description of all potential individual salt components to be used in addition to the polyglycol with a mean molecular weight of 3350 Ingredion, USA Farmal MN 5000 Mannitol Standard oral grade Used as a diluent for ODT and also used in sugar free tablets Farmal MN 5010 Injectable grade Vehicle for lyophilised products Dulcent Aspartame Aspartame Used as a sweetner in powder, granules, ODT and liquid orals Dulcent Sucralose Sucralose Used as a sweetner in powder, granules, ODT and liquid orals 12
13 Our core business Pharmaceutical industry We source and supply a wide range of innovative, high-performance chemicals, intermediates, API and formulations for the pharmaceutical industry. Sourcing We source APIs, excipients, and intermediates from India as well as globally. We provide Regulatory support Technical assistance Logistics, warehousing and distribution Custom manufacturing Development services Quality assurance Strengthen service offerings We continually strengthen and expand our range of service offerings across the entire value chain. To ensure the long-term success of our business partners, we constantly deliver more value-added solutions that give them a competitive advantage. Your preferred partner for sourcing Comprehensive sourcing network in Asia, Europe and the Americas Proven track record Early trend scout Global technology transfers Highly dedicated team of sourcing specialists Increase operational efficiency We continuously improve the efficiency of our processes. The quality of our services is based on best practices and standards throughout our entire organization. An efficient supply chain coupled with synergies across all Business Units and countries allow us to fulfill the diverse requirements of the business we serve. Our key sourcing offices Japan Korea China India Europe The information in this brochure is to our best knowledge true and accurate but, all instructions, recommendations or suggestions are made without guarantee. Since the conditions of use are beyond their control, DKSH disclaims any liability for loss or damage suffered for use of this data or suggestions. Furthermore, no liability is accepted if use of any product in accordance with this data or suggestions infringes any patent. 13
14 Notes 14
15 15
16 Pharmaceutical industry Branch locations Ahmedabad Phone Kolkata Phone Delhi Phone /21 Mumbai Phone DKSH India Private Limited Fantree Building, Sarla Park, Andheri East, Mumbai , India Phone , Fax Secunderabad Phone
we ve got you covered pharmaceutical product and solution guide
we ve got you covered pharmaceutical product and solution guide 2 / we ve got you covered Helping to ensure the efficacy, integrity and usability of pharmaceutical formulations At Ashland, our number one
More informationVIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies
VIVAPHARM PVP/VA Copovidone, Ph.Eur. USP/NF, JPE, E 1208, FCC The Ultimate Tablet Binder for All Processing Technologies Direct Compression Dry Granulation Hot Melt Extrusion Wet Granulation VIVAPHARM
More informationBiopharmaceutics Dosage form factors influencing bioavailability Lec:5
Biopharmaceutics Dosage form factors influencing bioavailability Lec:5 Ali Y Ali BSc Pharmacy MSc Industrial Pharmaceutical Sciences Dept. of Pharmaceutics School of Pharmacy University of Sulaimani 09/01/2019
More informationSTARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant
EXCIPIENTS STARCH 1500 Proven and Trusted Excipient for Performance and Versatility Effective and economical disintegrant Excellent stability for moisture sensitive drugs Manufactured exclusively for the
More informationEasy, fast and reliable!
Product Overview Easy, fast and reliable! Special easy-to-use preparations for film coating, sugar-coating, colouring and tabletting. Tailormade formulated. s film coating products are one-step coating
More informationTo study the effect that hydroxypropylcellulose (HPC) polymer molecular weight (MW) exerts on drug release rates and mechanism from matrix tablets.
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-029-1 (Supersedes PTR 029) Page 1 of 7 Hydroxypropylcellulose in Modified Release Matrix Systems: Polymer Molecular Weight Controls
More informationCritical material properties for the design of robust drug products : excipient functionality related characteristics
Critical material properties for the design of robust drug products : excipient functionality related characteristics Dr Liz Meehan, Pharmaceutical Development, Macclesfield UK 1 Excipients Definition
More informationEXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER. Life-saving pharmaceuticals start with high-quality ingredients
EXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER Life-saving pharmaceuticals start with high-quality ingredients CONFIDENCE STRAIGHT FROM THE SOURCE From oral dosage excipients (Rx, Gx, nutraceuticals
More informationEasy, fast and reliable!
Product Overview Easy, fast and reliable! Special easy-to-use preparations for film coating, sugar-coating, colouring and tabletting. s film coating products are one-step coating systems for pharmaceutical
More informationEvaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig
PHARMACEUTICAL THNOLOGY REPORT Consumer Specialties ashland.com PTR 11 Page 1 of 5 Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig Objectives When preparing tablets by roller
More informationFLORITER. New Technology for Innovative Formulation Design.
FLORITER New Technology for Innovative Formulation Design www.tomitaph.co.jp FLORITE Dramatically Change Your Formulation FLORITE is synthetic Calcium Silicate with exceptional liquid absorbency and excellent
More informationTECHNICAL INFORMATION RxCIPIENTS FM A versatile excipient for orally disintegrating tablet (ODT) formulations
TECHNICAL INFORMATION 1426 RxCIPIENTS FM 1 A versatile excipient for orally disintegrating tablet (ODT) formulations Table of contents 1 Introduction 3 2 Mode of action and advantages of RxCIPIENTS FM
More informationEtat des travaux du GDP
Etat des travaux du GDP (Avril 2018) Item General methods relevant to Q6A Dissolution (rev. 3) 4 Disintegration (rev. 1) 4 Uniformity of content/mass (rev. 2, corr. 1) 4 Tests for specified microorganisms
More informationLubriTose Mannitol Michael Crowley, Director of R&D, Excipients
LubriTose Mannitol Michael Crowley, Director of R&D, Excipients Introduction Michael Crowley Director of R&D Excipients 158 St. Highway 320 Norwich, NY 13815 PH 315-802-5970 Michael.Crowley@Kerry.com 2
More informationExcipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical
Excipient Quality & Trouble Shooting By Seema Trivedi GM, Technical Back Ground The Society for Pharmaceutical Dissolution Science (SPDS) had held its 6th Annual International Convention Disso India -
More informationORAL DOSAGE OVERVIEW
ORAL DOSAGE OVERVIEW AN UNWAVERING COMMITMENT TO ENABLING LIFE-SAVING PHARMACEUTICALS The safety of your patients is your number one priority. That s why the quality and stability of your formulations
More informationGuidance on Pharmaceutical Excipient Suitability Studies (PESS) with Chinese Pharmacopeia (Volume 4): Basics and Examples
Guidance on Pharmaceutical Excipient Suitability Studies (PESS) with Chinese Pharmacopeia (Volume 4): Basics and Examples Professor Jiasheng Tu, Ph. D. France 2018/09 content 1 Introduction 2 PESS guidance
More informationEP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2010/39
(19) (12) EUROPEAN PATENT APPLICATION (11) EP 2 233 131 A1 (43) Date of publication: 29.09. Bulletin /39 (1) Int Cl.: A61K 9/ (06.01) A61K 31/00 (06.01) (21) Application number: 09908.8 (22) Date of filing:
More informationREVISION OF MONOGRAPH ON TABLETS. Tablets
March 2011 REVISION OF MONOGRAPH ON TABLETS Final text for addition to The International Pharmacopoeia This monograph was adopted by the Forty-fourth WHO Expert Committee on Specifications for Pharmaceutical
More informationPHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Experimental Methods
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-8 Page 1 of 6 Are Cellulosic Controlled Release Technologies Vulnerable to Dose Dumping in Ethanolic Dissolution Media? Elanor Pinto,
More informationMETOLOSE: CONTENTS PAGE
METOLOSE: CONTENTS PAGE 2 Preface What is Metolose Substitution types Specifications 1) Available grades & viscosity 2) Nomenclature 3) Packaging Characteristics of Metolose Properties of Metolose 1) Powder
More informationTABLET DESIGN AND FORMULATION
TABLET DESIGN AND FORMULATION PART 5 Industrial pharmacy 5th class 1st semester TABLET DESIGN AND FORMULATION Conventional oral tablets for ingestion usually contain the same classes of components in addition
More informationCHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION
CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION LEARNING OBJECTIVES The objectives of this unit are to: Understand the formulation of solid dosage form. Understand the characteristic
More informationCONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications
Hypromellose CONTENTS PAGE 2 Preface Matrix system Selection of METOLOSE grades Specifications Properties Powder Solution Application Related Patents 3 4-5 6 8 10 13 14 17 Please note: The information
More informationDVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ
QbD Approach to Formulation of Hydrophilic Matrix Using Sample Kit of Hypromellose [Metolose SR] DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa,
More informationFormulation and Evaluation
Chapter-5 Formulation and Evaluation 5.1 OBJECTIVE After successful taste masking and solubility enhancement of drugs in preliminary studies, by using Mannitol Solid Dispersion, next step includes the
More informationPHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY
PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY Excipients are inactive ingredients used as carriers for the active ingredients in a pharmaceutical product. These may
More informationDow Wolff Cellulosics. Using ingenuity and savvy. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow
Dow Wolff Cellulosics Pharmaceutical Excipients Using ingenuity and savvy to help design healthcare solutions TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow Enhancing
More informationSENTRY TM POLYOX Water Soluble Resins
SENTRY TM POLYOX Water Soluble Resins Technical Information on Stability Introduction Key Points Antioxidants SENTRY POLYOX WSR resins consist of a family of high molecular weight polyethers with nominal
More informationAnimal Health. Premixes Dietary Fibers. and Gels Solid. Dosage Forms. Liquids. Product Overview. Customize Your Formulation
Animal Health Product Overview Liquids and Gels Solid Dosage Forms Premixes Dietary Fibers Customize Your Formulation ANIMAL HEALTH Product Overview General Information Liquids and Gels Healthcare is essential
More informationANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section.
2. EXCIPIENTS PROFILES ANNEXURE -2 Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section. 2.1. COMPRITOL 888 Non proprietary names BP:
More informationLYCOAT. New solutions for Film Coating from Roquette. LYCOAT for quicker quality coating
LYCOAT New solutions for Film Coating from Roquette LYCOAT for quicker quality coating Roquette LYCOAT New solutions for Film Coating from Roquette LYCOAT New solutions for Film Coating Film coating, the
More informationWherever life takes you BASF excipients for orally disintegrating tablets make medication easy
Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy Dr. Philipp Hebestreit, an enabler in excipients Pharma Ingredients & Services. Welcome to more opportunities.
More informationExcipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015
Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015 Dr. Susanne Keitel Director EDQM, Council of Europe Outline 1. The European Pharmacopoeia 2. The importance of
More informationInnovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017
Innovations in Design: NIA-West Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017 1 Innovations in Design: How Do You Stand Out? If all other competitors are the same
More informationEP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION
(19) (11) EP 1 864 677 B1 (12) EUROPEAN PATENT SPECIFICATION (4) Date of publication and mention of the grant of the patent: 02.01.08 Bulletin 08/01 (1) Int Cl.: A61K 38/ (06.01) A61K 9/ (06.01) A61K 31/39
More informationExcipients make the difference! Dr. Felicitas Guth Global Technical Service Excipients Pharma Ingredients & Services BASF SE
Excipients make the difference! Dr. Felicitas Guth Global Technical Service Excipients Pharma Ingredients & Services BASF SE Paradigm shift in pharmaceutical development Traditional medicinal products
More informationSUMMARY AND CONCLUSION
SUMMARY AND CONCLUSION 8 SUMMARY AND CONCLUSIONS In spite of the many challenges faced by researchers while designing an effective, reproducible and stable dosage form, oral dosage forms continued to maintain
More informationFORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels
Seite 1 von 8 Share this story: Issue: April 2015, Posted Date: 3/30/2015 FORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels INTRODUCTION Soft gelatin capsules (softgels) continue
More informationPharmaceutical Preparation For Internal Use
Pharmaceutical Preparation For Internal Use 1. Solid Preparations (Tablet, Capsule, Pill) 2. Liquid Preparations (Aqua, Syrup, Elixir, Extract, Liquor, Emulsion, Mixture, Infusion, Decoction). 3. Powder
More informationCo-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009
Co-Processed Excipients: Regulatory Challenges Carl Mroz Colorcon Limited June 2009 What is a Co-Processed excipient? Several types of excipient contain multiple components by design Use of processing
More informationLAB.2. Tablet Production Methods
LAB.2 Tablet Production Methods Dry methods Direct compression Dry granulation Wet methods Wet granulation Regardless whether tablets are made by direct compression or granulation, the first step, milling
More informationHydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems D. Tewari, R. K. Lewis, W. W. Harcum and T Dürig
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-069-1 (Supersedes PTR-069) Page 1 of 8 Hydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems
More informationPHARMACEUTICAL TECHNOLOGY REPORT. Abstract Summary. Introduction. Experimental Methods. Consumer Specialties ashland.com
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-037-3 (Supersedes PTR-037-2) Page 1 of 7 Hydrodynamic Robustness of Hypromellose and Hydroxypropyl Cellulose Based Modified Release
More information(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )
(19) TEPZZ 94677_A_T (11) (12) EUROPEAN PATENT APPLICATION (43) Date of publication: 2.11.1 Bulletin 1/48 (1) Int Cl.: A61K 9/ (06.01) A61K 31/41 (06.01) (21) Application number: 116790.3 (22) Date of
More informationSCIENTIFIC DISCUSSION. Efavirenz
SCIENTIFIC DISCUSSION Name of the Finished Pharmaceutical Product: Manufacturer of Prequalified Product: Active Pharmaceutical Ingredient (API): Pharmaco-therapeutic group (ATC Code): Therapeutic indication:
More informationTable 1 Hydrophilicity of MC and HPMC Grades. Polymer Cloud Point ( C) Hydrophilicity MC HPMC Type 2910 HPMC Type
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-046-1 (Supersedes PTR-046) Page 1 of 6 Effect of Hypromellose and Methylcellulose Substitution Type, Molecular Weight and Drug Solubility
More informationIngredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose
1 Pharmaceutical industry borrowed ingredients from other industries Food Cosmetic Industrial Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work that has all changed
More informationPRESS RELEASE. Food Ingredients Asia 2013: WACKER Showcases Highly Bioavailable Curcumin. Number 51
Wacker Chemie AG Hanns-Seidel-Platz 4 81737 München, Germany www.wacker.com PRESS RELEASE Number 51 Food Ingredients Asia 2013: WACKER Showcases Highly Bioavailable Curcumin Munich/Bangkok, September 11,
More informationNew formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability
New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability Andreas Gryczke, an enabler in excipients Pharma Ingredients & Services. Welcome to more opportunities.
More informationFormulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch
Abstract K.P.R. Chowdary et al. / International Journal of Pharma Sciences and Research (IJPSR) Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch K.P.R. Chowdary*,
More informationChallenges and solutions for moisture sensitive API formulation
Challenges and solutions for moisture sensitive API formulation Introduction Today, formulators are looking for alternative processes to reformulate existing products or to formulate New Chemical Entities
More informationFormulation Study for Lansoprazole Fast-disintegrating Tablet. II. Effect of Triethyl Citrate on the Quality of the Products
September 2003 Chem. Pharm. Bull. 51(9) 1029 1035 (2003) 1029 Formulation Study for Lansoprazole Fast-disintegrating Tablet. II. Effect of Triethyl Citrate on the Quality of the Products Toshihiro SHIMIZU,*
More informationKollicoat Smartseal 30 D Active Protection
Pharma Ingredients & Services. Welcome to more opportunities. Custom Synthesis Excipients Active Ingredients Kollicoat Smartseal 3 D Active Protection Breaking new ground in taste masking and moisture
More informationThe unlocked synergy of DFE Pharma MCC
The unlocked synergy of DFE Pharma MCC We are DFE Pharma We are the global leader in excipient solutions. We develop, produce and market excipients for oral solid dose and dry powder inhalation formulations.
More information02/09/2016. Roles of Excipients in Pharmaceuticals:
Definition: Any substance other than the active drug or prodrug that is included in the manufacturing process or is contained in a finished pharmaceutical dosage form. Excipients are not inactive and have
More informationYOUR ORAL SOLID DOSE. In pursuit of excipient excellence
YOUR ORAL SOLID DOSE DFE Pharma globally supplies a unique, broad portfolio of key excipients including lactose, MCC, superdisintegrants and starches. Innovative products such as SuperTab 24AN and SuperTab
More informationDirect Compression. With the right ingredients it s a simple, cost-effective manufacturing process
Direct With the right ingredients it s a simple, cost-effective manufacturing process TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow Speed and savings sounds good to us
More informationTEPZZ Z697_5A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: A61K 9/20 ( ) A61K 31/135 (2006.
(19) TEPZZ Z697_A_T (11) EP 3 069 7 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: 21.09.16 Bulletin 16/38 (1) Int Cl.: A61K 9/ (06.01) A61K 31/13 (06.01) (21) Application number: 160172.1
More informationPrincipals and Dosage Forms in the Therapy Modified Drug Release. Institute of Pharmaceutical Technology and Biopharmacy
Principals and Dosage Forms in the Therapy Modified Drug Release Institute of Pharmaceutical Technology and Biopharmacy Dosage forms Definition: Dosage forms are the means by which drug molecules are delivered
More informationFunctional Excipients for Suppository Applications
Functional Excipients for Suppository Applications Skin Delivery Platform 2016 1 The Skin Delivery Platform Major areas of activity are in 4 pillars PLATFORM : SKIN DELIVERY Dermal Drug Delivery Mildness
More informationSoluplus The Solid Solution Opening New Doors in Solubilization.
Soluplus The Solid Solution Opening New Doors in Solubilization. Dr. Shaukat Ali, an enabler in excipients Pharma Ingredients & Services. Welcome to more opportunities. Custom Synthesis Excipients Active
More informationApplication of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products
57. Starch Convention, Detmold, April 26-28, 2006 K.-J. Steffens Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products Starches, Pharmaceutical Applications _ Starches
More informationRationale of and Experience with the Expert System
Rationale of and Experience with the Expert System Professor Mitsuru HASHIDA Roland DAUMESNIL Lecture presented during the Controlled Release Society Symposium Optimization of Oral Drug Delivery Hong Kong
More informationNon-Food Uses of Polysaccharides
Non-Food Uses of Polysaccharides John Mitchell John.Mitchell@biopolymersolutions.co.uk Acknowledgements Fundamentals of Hydrocolloid Technology Course (2003-2009) Rob Winwood Colin Melia Steve Harding
More informationZHONGBAO CHEMICALS CO.,LTD
ZHONGBAO CHEMICALS CO.,LTD HANGZHOU ZHONGBAO IMP & EXP CORP.,LTD SINCE 1963 An ISO9001:2000 company Zhongbao Chemicals Co.,LTD is one of the world s specialty chemical companies-including manufacturing
More informationCAPMUL + CAPTEX + ACCONON = SEDDS
OUR SOLUTIONS PORTFOLIO ABITEC products are specifically designed for meeting the solubility challenges of the pharmaceutical industry. Our products can be used alone or in conjunction with one another
More informationA Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac
Asian Journal of Chemistry Vol. 22, No. 6 (2010), 4239-4244 A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac K.P.R. CHOWDARY*
More information( 12 ) Patent Application Publication ( 10 ) Pub. No.: US 2017 / A1
THE LETTERIN US 20170231969A1 MUTTU 19 United States ( 12 ) Patent Application Publication ( 10 ) Pub. No.: US 2017 / 0231969 A1 Raneburger et al. ( 43 ) Pub. Date : Aug. 17, 2017 ( 54 ) PHARMACEUTICAL
More informationSCIENTIFIC DISCUSSION
This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1
More informationCHEWABLE SOFTGEL TECHNOLOGY
CHEWABLE SOFTGEL TECHNOLOGY PROCAPS AT A GLANCE Procaps is a Pharmaceutical Group dedicated to delivering innovation, health and Nutrition. We work hand in hand with our customers and develop products
More informationShort Communication. Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L. J. TIROP AND K. A. M.
61 East and Central African Journal of Pharmaceutical Sciences Vol. 18 (2015) 61-66 Short Communication Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L.
More informationDRY SYRUPS SWAPNA.M. Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL SEMINAR BY
DRY SYRUPS SEMINAR BY SWAPNA.M M.PHARMACY Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL CONTENTS DEFINITION CHARACTERISTICS OF SUSPENSIONS
More informationPublic Assessment Report. Scientific discussion. Venlafaxin SUN 37.5 mg, 75 mg and 150 mg prolonged-release tablets. (venlafaxine hydrochloride)
Public Assessment Report Scientific discussion Venlafaxin SUN 37.5 mg, 75 mg and 150 mg prolonged-release tablets (venlafaxine hydrochloride) NL/H/3948/001-003/DC Date: 6 January 2016 This module reflects
More informationKollidon CL Kollidon CL-F Kollidon CL-SF Kollidon CL-M. Super-disintegrants and dissolution enhancers.
Kollidon CL Kollidon CL-F Kollidon CL-SF Kollidon CL-M Super-disintegrants and dissolution enhancers. 2 The Preface New: 4 dimensions of Kollidon CL standard, fine (CL-F), superfine (CL-SF) and micronized
More informationTexturizing Solutions: Serving customers across categories
Texturizing Solutions: Serving customers across categories Starches Soy* Lecithin Hydrocolloids** FS Bakery Beverage Confectionery Convenience foods Dairy Fruit Infant and Baby food Meat Petfood native
More informationFood supplement manufacture
Food supplement manufacture Nick Bennett BSc. RNutr April 2018 1 Introduction There are many different product formats available Liquids, powders, tablets, capsules etc Many different types of machine
More informationUSP Excipients Standards Setting Process
USP Stakeholder Forum, Meeting #1 June 7, 2013 USP Excipients Standards Setting Process Catherine M. Sheehan, M.S., M.S. Sr. Director, Excipients US P Convention cxs@usp.org Historical Background on the
More informationFolic Acid in Human Nutrition
Folic Acid in Human Nutrition Folic acid is a water soluble B vitamin widely distributed in foods. Deficiencies lead to impaired cell division and altered protein synthesis. Newborn children of women receiving
More informationI International Bureau (10) International Publication Number (43) International Publication Date
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International
More informationLarge scale production
Large scale production Rotary capsule machine: This machine has two, side-by-side cylinders in each of which half-moulds are cut. These cylinders, like the rollers of a mangle, rotate in contrary direction
More informationPHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION
PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION 1 PHARMACEUTICS Pharmaceutics is the science of dosage form design. The general area of study concerned with the formulation, manufacture, stability, and
More information3. Drug or plant or excipients profile
3. Drug or plant or excipients profile 3. 1 Analysis of Reference Listed Drug (RLD) Product ABILIFY (aripiprazole) 3.1.1 Clinical The Reference Listed Drug (RLD) is Brand ABILIFY (aripiprazole) Tablets
More informationAnyCoat. From Nature, Beside you.
AnyCoat From Nature, Beside you www.lotte-cellulose.com 04 AnyCoat is 05 Certificates of AnyCoat AnyCoat-C 06 General Characteristics 07 Specifications 08 Chemical Structure, Nomenclature 09 Functional
More informationThe binding performance of DFE Pharma Starch
The binding performance of DFE Pharma Starch MCC Starch Lactose Inhalation Superdisintegrants We are DFE Pharma We are the global leader in excipient solutions. We develop, produce and market excipients
More informationREGULATORY PERSPECTIVE. Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore
1 REGULATORY PERSPECTIVE Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore Contents 2 1. Role of Dissolution Testing in Generic Drug Approval 2. Dissolution Testing Recommendation for Solid Oral
More informationEvaluation of Moisture Sorption Methods for Aqueous Moisture Barrier Coatings D. Tewari, R. Lewis, B. Kinsey and T. Dürig*
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-039-2 (Supersedes PTR-039-1) Page 1 of 9 Evaluation of Moisture Sorption Methods for Aqueous Moisture Barrier Coatings D. Tewari, R.
More informationEUDRAGIT L 100 and EUDRAGIT S 100
Technical Information EUDRAGIT L 100 and EUDRAGIT S 100 Specification and Test Methods Ph. Eur. Methacrylic Acid - Methyl Methacrylate Copolymer (1:1) Methacrylic Acid - Methyl Methacrylate Copolymer (1:2)
More informationGLYCOLYS
ROQUETTE WORLDWIDE EUROPE FRANCE Roquette Frères Corporate Headquarters 62080 Lestrem cedex - France Telephone: + 33 3 21 63 36 00 Fax: + 33 3 21 63 38 50 FINLAND Roquette Nordica Oy PL 11 P.O.B FIN-02171
More informationPaper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives
Paper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives 2.1 Introduction According to the Food Protection Committee of the Food and Nutrition Board, food additives
More informationWhy and how does a pharmaceutical company take the risk to use novel excipients?
Why and how does a pharmaceutical company take the risk to use novel excipients? M. Sherry Ku, Ph.D. CSO, Anchen Pharmaceuticals Irvine, CA Excipient Fest, May 5, 2010 Puerto Rico Global Excipient Acceptability
More informationFORMULATION AND EVALUATION OF THEOPHYLLINE BILAYERED TABLETS USING HPC AS MATRIX MATERIAL
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article FORMULATION AND EVALUATION OF THEOPHYLLINE BILAYERED TABLETS USING HPC AS MATRIX MATERIAL
More informationSCIENTIFIC DISCUSSION
SCIENTIFIC DISCUSSION Name of the Finished Pharmaceutical Product: Manufacturer of Prequalified Product: Active Pharmaceutical Ingredients (APIs): Pharmaco-therapeutic group (ATC Code): Therapeutic indication:
More informationUniversity of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester
University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester 5/21/2017 Pharmaceutical Compounding, Dr. rer. nat. Rebaz Ali 1 Outlines Why rectal or vaginal route? Suppository
More informationBaerlocher Additives for PVC. Lubricants
Baerlocher Additives for PVC Lubricants we add character to plastics The Baerlocher Group of Companies is one of the world s leading suppliers of additives for the plastics industry with a strong focus
More informationFORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES
Int. J. Chem. Sci.: 10(1), 2012, 297-305 ISSN 0972-768X www.sadgurupublications.com FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES K. P.
More informationFormulation and evaluation of oro-dispersible tablets of lafutidine
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (5):226-235 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationTechnical brochure StarLac
T R TABLETING AC DIRECT COMPRESSION CO-PROCESSED LACTOSE Technical brochure MEGGLE co-processed lactose grades for direct compression: General information Direct compression (DC) tablet manufacture is
More informationDesigned and manufactured specifically for pharmaceutical capsule filling
EXCIPIENTS Designed and manufactured specifically for pharmaceutical capsule filling Simple formulation Superior flow and weight uniformity Clean and efficient processing This document is valid at the
More informationFormulation Development of Etoricoxib Tablets by Wet Granulation and Direct Compression Methods Employing Starch Phosphate
International Journal of Pharmacology and Technology 3(1), June 2011, pp. 9-15 Formulation Development of Etoricoxib Tablets by Wet Granulation and Direct Compression Methods Employing Starch Phosphate
More information